Weekender 11/14/14

We take the trust that our Member Investors have placed in BioNJ very seriously, and we hope you will concur that our enhanced Vision. Mission and Strategic Initiatives which form the foundation of our new brand, BioNJ: The Gateway to Health, is a good use of your Investment in BioNJ.

We are heartened by the level of support and encouragement that has followed last week’s announcement. Your response has fortified our strong resolve to help companies help patients ,,, Because Patients Can’t Wait In the next few weeks and months, we will continue to roll out the initiatives we have announced. And we will also be announcing additional initiatives. Click Here if you haven’t had a chance to catch up with the telecast and Click Here to read the press release. And as always, there is a lot of great New Jersey news to report. Look below to read about Valeant Pharmaceuticals’ plans to add 500 jobs over the next two years, the growth of Cancer Genetics being recognized in a Deloitte report and how engineers at NJIT are helping in the fight again Ebola, PTC Therapeutics being recognized for Outstanding Innovation at the 2014 Rare and Orphan Advocacy and Research Awards…and much, much more.

Click here to read this week’s Weekender.